Fig. 2 | Scientific Reports

Fig. 2

From: Temporal changes of hepatic drug-metabolizing enzymes mediated by hepatic ischemia-reperfusion injury and the protective effect of Oridonin

Fig. 2

Effect of oridonin on liver and CYPs/UGTs of normal mice. (A) Chemical structure of oridonin. (B) The plasma ALT and AST levels of normal mice treated with oridonin (n = 6). (C) HE staining results of hepatic tissue in normal mice treated with oridonin (n = 3). (D) Induction of CYPs/UGTs in normal mice by oridonin (n = 6). (*p < 0.05, **p < 0.01, ***p < 0.001, ns: no significance)

Back to article page